Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 2 |
GO:0016020 | membrane | 2 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
Related structures:
AlphaFold database: Q4Q2I5
Term | Name | Level | Count |
---|---|---|---|
GO:0006629 | lipid metabolic process | 3 | 5 |
GO:0006644 | phospholipid metabolic process | 4 | 5 |
GO:0006650 | glycerophospholipid metabolic process | 5 | 5 |
GO:0006661 | phosphatidylinositol biosynthetic process | 6 | 5 |
GO:0006793 | phosphorus metabolic process | 3 | 11 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 11 |
GO:0007165 | signal transduction | 2 | 11 |
GO:0008152 | metabolic process | 1 | 11 |
GO:0008610 | lipid biosynthetic process | 4 | 5 |
GO:0008654 | phospholipid biosynthetic process | 5 | 5 |
GO:0009058 | biosynthetic process | 2 | 5 |
GO:0009987 | cellular process | 1 | 11 |
GO:0016310 | phosphorylation | 5 | 11 |
GO:0019637 | organophosphate metabolic process | 3 | 5 |
GO:0035556 | intracellular signal transduction | 3 | 11 |
GO:0044237 | cellular metabolic process | 2 | 11 |
GO:0044238 | primary metabolic process | 2 | 5 |
GO:0044249 | cellular biosynthetic process | 3 | 5 |
GO:0044255 | cellular lipid metabolic process | 3 | 5 |
GO:0045017 | glycerolipid biosynthetic process | 4 | 5 |
GO:0046474 | glycerophospholipid biosynthetic process | 5 | 5 |
GO:0046486 | glycerolipid metabolic process | 4 | 5 |
GO:0046488 | phosphatidylinositol metabolic process | 6 | 5 |
GO:0046854 | phosphatidylinositol phosphate biosynthetic process | 7 | 5 |
GO:0048015 | phosphatidylinositol-mediated signaling | 5 | 11 |
GO:0048017 | inositol lipid-mediated signaling | 4 | 11 |
GO:0050789 | regulation of biological process | 2 | 11 |
GO:0050794 | regulation of cellular process | 3 | 11 |
GO:0065007 | biological regulation | 1 | 11 |
GO:0071704 | organic substance metabolic process | 2 | 5 |
GO:0090407 | organophosphate biosynthetic process | 4 | 5 |
GO:1901576 | organic substance biosynthetic process | 3 | 5 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 11 |
GO:0004430 | 1-phosphatidylinositol 4-kinase activity | 6 | 8 |
GO:0016301 | kinase activity | 4 | 11 |
GO:0016740 | transferase activity | 2 | 11 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 3 | 11 |
GO:0016773 | phosphotransferase activity, alcohol group as acceptor | 4 | 8 |
GO:0052742 | phosphatidylinositol kinase activity | 5 | 8 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 134 | 138 | PF00656 | 0.775 |
CLV_MEL_PAP_1 | 539 | 545 | PF00089 | 0.252 |
CLV_NRD_NRD_1 | 13 | 15 | PF00675 | 0.512 |
CLV_NRD_NRD_1 | 158 | 160 | PF00675 | 0.444 |
CLV_NRD_NRD_1 | 192 | 194 | PF00675 | 0.401 |
CLV_NRD_NRD_1 | 198 | 200 | PF00675 | 0.402 |
CLV_NRD_NRD_1 | 335 | 337 | PF00675 | 0.456 |
CLV_NRD_NRD_1 | 438 | 440 | PF00675 | 0.460 |
CLV_NRD_NRD_1 | 598 | 600 | PF00675 | 0.452 |
CLV_NRD_NRD_1 | 7 | 9 | PF00675 | 0.583 |
CLV_PCSK_FUR_1 | 596 | 600 | PF00082 | 0.446 |
CLV_PCSK_KEX2_1 | 13 | 15 | PF00082 | 0.510 |
CLV_PCSK_KEX2_1 | 198 | 200 | PF00082 | 0.429 |
CLV_PCSK_KEX2_1 | 598 | 600 | PF00082 | 0.444 |
CLV_PCSK_KEX2_1 | 7 | 9 | PF00082 | 0.582 |
CLV_PCSK_SKI1_1 | 14 | 18 | PF00082 | 0.499 |
CLV_PCSK_SKI1_1 | 414 | 418 | PF00082 | 0.414 |
CLV_Separin_Metazoa | 147 | 151 | PF03568 | 0.493 |
DEG_APCC_DBOX_1 | 13 | 21 | PF00400 | 0.521 |
DEG_APCC_DBOX_1 | 197 | 205 | PF00400 | 0.465 |
DOC_CKS1_1 | 545 | 550 | PF01111 | 0.362 |
DOC_CYCLIN_yClb1_LxF_4 | 181 | 187 | PF00134 | 0.507 |
DOC_MAPK_gen_1 | 159 | 166 | PF00069 | 0.414 |
DOC_MAPK_gen_1 | 462 | 471 | PF00069 | 0.308 |
DOC_MAPK_MEF2A_6 | 159 | 166 | PF00069 | 0.436 |
DOC_MAPK_MEF2A_6 | 361 | 369 | PF00069 | 0.327 |
DOC_MAPK_MEF2A_6 | 473 | 482 | PF00069 | 0.381 |
DOC_PP1_RVXF_1 | 86 | 92 | PF00149 | 0.348 |
DOC_SPAK_OSR1_1 | 274 | 278 | PF12202 | 0.556 |
DOC_USP7_MATH_1 | 127 | 131 | PF00917 | 0.646 |
DOC_USP7_MATH_1 | 303 | 307 | PF00917 | 0.662 |
DOC_USP7_MATH_1 | 79 | 83 | PF00917 | 0.378 |
DOC_WW_Pin1_4 | 310 | 315 | PF00397 | 0.517 |
DOC_WW_Pin1_4 | 336 | 341 | PF00397 | 0.544 |
DOC_WW_Pin1_4 | 486 | 491 | PF00397 | 0.302 |
DOC_WW_Pin1_4 | 544 | 549 | PF00397 | 0.360 |
LIG_14-3-3_CanoR_1 | 13 | 17 | PF00244 | 0.503 |
LIG_14-3-3_CanoR_1 | 140 | 145 | PF00244 | 0.707 |
LIG_14-3-3_CanoR_1 | 171 | 180 | PF00244 | 0.447 |
LIG_14-3-3_CanoR_1 | 296 | 301 | PF00244 | 0.549 |
LIG_14-3-3_CanoR_1 | 334 | 340 | PF00244 | 0.472 |
LIG_14-3-3_CanoR_1 | 418 | 426 | PF00244 | 0.407 |
LIG_14-3-3_CanoR_1 | 88 | 94 | PF00244 | 0.316 |
LIG_APCC_ABBA_1 | 164 | 169 | PF00400 | 0.397 |
LIG_APCC_ABBA_1 | 275 | 280 | PF00400 | 0.361 |
LIG_APCC_ABBAyCdc20_2 | 163 | 169 | PF00400 | 0.394 |
LIG_APCC_ABBAyCdc20_2 | 274 | 280 | PF00400 | 0.367 |
LIG_BIR_III_2 | 311 | 315 | PF00653 | 0.595 |
LIG_BRCT_BRCA1_1 | 496 | 500 | PF00533 | 0.308 |
LIG_BRCT_BRCA1_1 | 514 | 518 | PF00533 | 0.308 |
LIG_Clathr_ClatBox_1 | 477 | 481 | PF01394 | 0.308 |
LIG_FHA_1 | 381 | 387 | PF00498 | 0.308 |
LIG_FHA_2 | 139 | 145 | PF00498 | 0.710 |
LIG_FHA_2 | 257 | 263 | PF00498 | 0.399 |
LIG_FHA_2 | 392 | 398 | PF00498 | 0.381 |
LIG_FHA_2 | 45 | 51 | PF00498 | 0.421 |
LIG_LIR_Gen_1 | 372 | 380 | PF02991 | 0.319 |
LIG_LIR_Gen_1 | 481 | 490 | PF02991 | 0.327 |
LIG_LIR_Gen_1 | 515 | 526 | PF02991 | 0.287 |
LIG_LIR_Gen_1 | 597 | 606 | PF02991 | 0.416 |
LIG_LIR_Nem_3 | 372 | 376 | PF02991 | 0.319 |
LIG_LIR_Nem_3 | 420 | 426 | PF02991 | 0.417 |
LIG_LIR_Nem_3 | 481 | 487 | PF02991 | 0.327 |
LIG_LIR_Nem_3 | 515 | 521 | PF02991 | 0.294 |
LIG_LIR_Nem_3 | 577 | 583 | PF02991 | 0.369 |
LIG_LIR_Nem_3 | 597 | 603 | PF02991 | 0.240 |
LIG_PCNA_yPIPBox_3 | 346 | 355 | PF02747 | 0.487 |
LIG_Pex14_2 | 373 | 377 | PF04695 | 0.308 |
LIG_Pex14_2 | 482 | 486 | PF04695 | 0.381 |
LIG_Pex14_2 | 87 | 91 | PF04695 | 0.360 |
LIG_Rb_pABgroove_1 | 35 | 43 | PF01858 | 0.502 |
LIG_SH2_CRK | 389 | 393 | PF00017 | 0.341 |
LIG_SH2_CRK | 452 | 456 | PF00017 | 0.312 |
LIG_SH2_STAP1 | 250 | 254 | PF00017 | 0.467 |
LIG_SH2_STAP1 | 41 | 45 | PF00017 | 0.499 |
LIG_SH2_STAP1 | 526 | 530 | PF00017 | 0.453 |
LIG_SH2_STAP1 | 580 | 584 | PF00017 | 0.461 |
LIG_SH2_STAT3 | 457 | 460 | PF00017 | 0.327 |
LIG_SH2_STAT5 | 246 | 249 | PF00017 | 0.381 |
LIG_SH2_STAT5 | 426 | 429 | PF00017 | 0.449 |
LIG_SH2_STAT5 | 457 | 460 | PF00017 | 0.381 |
LIG_SH2_STAT5 | 520 | 523 | PF00017 | 0.285 |
LIG_SH3_3 | 123 | 129 | PF00018 | 0.584 |
LIG_SH3_3 | 283 | 289 | PF00018 | 0.517 |
LIG_SH3_3 | 484 | 490 | PF00018 | 0.327 |
LIG_SUMO_SIM_anti_2 | 505 | 511 | PF11976 | 0.327 |
LIG_SUMO_SIM_anti_2 | 541 | 547 | PF11976 | 0.370 |
LIG_SUMO_SIM_par_1 | 399 | 407 | PF11976 | 0.414 |
LIG_TRAF2_1 | 29 | 32 | PF00917 | 0.526 |
LIG_TRAF2_1 | 47 | 50 | PF00917 | 0.423 |
LIG_TYR_ITIM | 248 | 253 | PF00017 | 0.461 |
LIG_TYR_ITIM | 524 | 529 | PF00017 | 0.420 |
LIG_UBA3_1 | 454 | 462 | PF00899 | 0.362 |
LIG_Vh1_VBS_1 | 78 | 96 | PF01044 | 0.241 |
LIG_WRC_WIRS_1 | 22 | 27 | PF05994 | 0.550 |
LIG_WRC_WIRS_1 | 370 | 375 | PF05994 | 0.415 |
MOD_CK1_1 | 130 | 136 | PF00069 | 0.719 |
MOD_CK1_1 | 139 | 145 | PF00069 | 0.691 |
MOD_CK1_1 | 220 | 226 | PF00069 | 0.486 |
MOD_CK1_1 | 409 | 415 | PF00069 | 0.428 |
MOD_CK1_1 | 544 | 550 | PF00069 | 0.379 |
MOD_CK2_1 | 140 | 146 | PF00069 | 0.731 |
MOD_CK2_1 | 228 | 234 | PF00069 | 0.346 |
MOD_CK2_1 | 236 | 242 | PF00069 | 0.429 |
MOD_CK2_1 | 26 | 32 | PF00069 | 0.445 |
MOD_CK2_1 | 296 | 302 | PF00069 | 0.689 |
MOD_CK2_1 | 43 | 49 | PF00069 | 0.423 |
MOD_GlcNHglycan | 133 | 136 | PF01048 | 0.753 |
MOD_GlcNHglycan | 220 | 223 | PF01048 | 0.422 |
MOD_GlcNHglycan | 28 | 31 | PF01048 | 0.513 |
MOD_GlcNHglycan | 305 | 308 | PF01048 | 0.630 |
MOD_GlcNHglycan | 405 | 409 | PF01048 | 0.353 |
MOD_GlcNHglycan | 496 | 499 | PF01048 | 0.302 |
MOD_GlcNHglycan | 590 | 593 | PF01048 | 0.478 |
MOD_GlcNHglycan | 96 | 99 | PF01048 | 0.463 |
MOD_GSK3_1 | 127 | 134 | PF00069 | 0.667 |
MOD_GSK3_1 | 136 | 143 | PF00069 | 0.687 |
MOD_GSK3_1 | 169 | 176 | PF00069 | 0.425 |
MOD_GSK3_1 | 216 | 223 | PF00069 | 0.522 |
MOD_GSK3_1 | 233 | 240 | PF00069 | 0.458 |
MOD_GSK3_1 | 40 | 47 | PF00069 | 0.481 |
MOD_GSK3_1 | 414 | 421 | PF00069 | 0.419 |
MOD_GSK3_1 | 58 | 65 | PF00069 | 0.324 |
MOD_GSK3_1 | 94 | 101 | PF00069 | 0.448 |
MOD_N-GLC_1 | 178 | 183 | PF02516 | 0.413 |
MOD_N-GLC_1 | 228 | 233 | PF02516 | 0.500 |
MOD_N-GLC_1 | 26 | 31 | PF02516 | 0.545 |
MOD_N-GLC_1 | 345 | 350 | PF02516 | 0.482 |
MOD_NEK2_1 | 173 | 178 | PF00069 | 0.409 |
MOD_NEK2_1 | 180 | 185 | PF00069 | 0.426 |
MOD_NEK2_1 | 217 | 222 | PF00069 | 0.456 |
MOD_NEK2_1 | 324 | 329 | PF00069 | 0.461 |
MOD_NEK2_1 | 369 | 374 | PF00069 | 0.387 |
MOD_NEK2_1 | 445 | 450 | PF00069 | 0.312 |
MOD_NEK2_1 | 485 | 490 | PF00069 | 0.341 |
MOD_NEK2_1 | 53 | 58 | PF00069 | 0.336 |
MOD_NEK2_1 | 99 | 104 | PF00069 | 0.538 |
MOD_NEK2_2 | 380 | 385 | PF00069 | 0.453 |
MOD_NMyristoyl | 1 | 7 | PF02799 | 0.510 |
MOD_PIKK_1 | 500 | 506 | PF00454 | 0.308 |
MOD_PK_1 | 418 | 424 | PF00069 | 0.347 |
MOD_PKA_1 | 414 | 420 | PF00069 | 0.414 |
MOD_PKA_2 | 12 | 18 | PF00069 | 0.495 |
MOD_PKA_2 | 139 | 145 | PF00069 | 0.707 |
MOD_PKA_2 | 330 | 336 | PF00069 | 0.478 |
MOD_PKA_2 | 417 | 423 | PF00069 | 0.407 |
MOD_PKA_2 | 541 | 547 | PF00069 | 0.254 |
MOD_Plk_1 | 152 | 158 | PF00069 | 0.553 |
MOD_Plk_1 | 169 | 175 | PF00069 | 0.479 |
MOD_Plk_1 | 228 | 234 | PF00069 | 0.425 |
MOD_Plk_1 | 345 | 351 | PF00069 | 0.455 |
MOD_Plk_1 | 43 | 49 | PF00069 | 0.429 |
MOD_Plk_1 | 432 | 438 | PF00069 | 0.420 |
MOD_Plk_2-3 | 256 | 262 | PF00069 | 0.428 |
MOD_Plk_2-3 | 406 | 412 | PF00069 | 0.381 |
MOD_Plk_2-3 | 44 | 50 | PF00069 | 0.465 |
MOD_Plk_2-3 | 573 | 579 | PF00069 | 0.411 |
MOD_Plk_4 | 152 | 158 | PF00069 | 0.607 |
MOD_Plk_4 | 233 | 239 | PF00069 | 0.428 |
MOD_Plk_4 | 296 | 302 | PF00069 | 0.628 |
MOD_Plk_4 | 418 | 424 | PF00069 | 0.362 |
MOD_Plk_4 | 432 | 438 | PF00069 | 0.368 |
MOD_Plk_4 | 450 | 456 | PF00069 | 0.321 |
MOD_Plk_4 | 473 | 479 | PF00069 | 0.453 |
MOD_Plk_4 | 541 | 547 | PF00069 | 0.382 |
MOD_ProDKin_1 | 310 | 316 | PF00069 | 0.504 |
MOD_ProDKin_1 | 336 | 342 | PF00069 | 0.537 |
MOD_ProDKin_1 | 486 | 492 | PF00069 | 0.302 |
MOD_ProDKin_1 | 544 | 550 | PF00069 | 0.360 |
TRG_DiLeu_BaEn_1 | 209 | 214 | PF01217 | 0.498 |
TRG_ENDOCYTIC_2 | 250 | 253 | PF00928 | 0.429 |
TRG_ENDOCYTIC_2 | 389 | 392 | PF00928 | 0.327 |
TRG_ENDOCYTIC_2 | 452 | 455 | PF00928 | 0.295 |
TRG_ENDOCYTIC_2 | 520 | 523 | PF00928 | 0.308 |
TRG_ENDOCYTIC_2 | 526 | 529 | PF00928 | 0.308 |
TRG_ENDOCYTIC_2 | 600 | 603 | PF00928 | 0.422 |
TRG_ER_diArg_1 | 197 | 199 | PF00400 | 0.447 |
TRG_ER_diArg_1 | 566 | 569 | PF00400 | 0.374 |
TRG_ER_diArg_1 | 595 | 598 | PF00400 | 0.450 |
TRG_Pf-PMV_PEXEL_1 | 14 | 18 | PF00026 | 0.374 |
TRG_Pf-PMV_PEXEL_1 | 202 | 206 | PF00026 | 0.407 |
TRG_Pf-PMV_PEXEL_1 | 35 | 39 | PF00026 | 0.537 |
TRG_Pf-PMV_PEXEL_1 | 522 | 527 | PF00026 | 0.435 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I2J4 | Leptomonas seymouri | 74% | 97% |
A0A0S4JIN0 | Bodo saltans | 47% | 100% |
A0A1X0PA54 | Trypanosomatidae | 53% | 100% |
A0A3S7X8H7 | Leishmania donovani | 95% | 100% |
A0A422N5M8 | Trypanosoma rangeli | 51% | 100% |
A4HB77 | Leishmania braziliensis | 85% | 100% |
A4IAC5 | Leishmania infantum | 95% | 100% |
A4QPH2 | Homo sapiens | 27% | 100% |
C9ZLW7 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 49% | 100% |
E9B5E8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 92% | 100% |